Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases. We have licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a first-in-class potassium-competitive acid blocker (PCAB). Phathom currently markets VOQUEZNA® (vonoprazan) tablets for the treatment of Erosive GERD and associated heartburn in adults, as well as VOQUEZNA® TRIPLE PAK® (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA® DUAL PAK® (vonoprazan tablets, amoxicillin capsules) for the treatment of H. pylori infection in adults. In addition, the company is actively investigating the use of vonoprazan as a treatment for Non-Erosive GERD, with a New Drug Application currently under review by the FDA and a separate Phase 3 trial planned to initiate in 2024.
We believe we can change the status quo of treatment for acid-related disorders and have assembled a team of seasoned GI and pharmaceutical industry experts with deep expertise in developing blockbuster therapeutics, including anti-secretory agents. Our team of highly driven professionals are passionate in our mission to address unmet needs for patients and improve their quality of life. Phathom is looking for self-motivated, creative problem solvers who are excited by the idea of working in a fast-paced environment and contributing to our growth.
The Manager, Investor Relations and Business Development will be responsible for supporting all operational activities related to the function including coordination of investor events, providing investor intelligence, monitoring analyst perceptions, crafting strategic messages, and assisting with relevant business development transactions. This role will have the opportunity for exposure to members of the C-suite and will be privy to core elements of company strategy. We are seeking candidates with strong communication skills, analytical acumen, attention to detail, and interest in being fundamental to the success of the overall organization. We welcome candidates with various background experience, with a focus on those driven to learn and excel.
ACCOUNTABILITIES:
Supporting the ongoing refinement and positioning of strategic external messages
Assisting in the development of materials required for quarterly earnings calls and board meetings
Maintaining a pulse on biotech/pharma capital markets, investor sentiment, and peer messaging
Supporting the coordination of all investor events (e.g., conferences, roadshows, fireside chats)
Preparing management for investor interactions as the primary source of account intelligence
Analyzing and drawing actionable insights from data (e.g., industry deals, stock performance)
Owning the latest understanding of PHAT's shareholder base (i.e., using reporting and surveillance)
Performing in-depth reviews of wall-street analysts' research reports and valuation modeling, including monitoring of assumptions and resulting consensus estimates
Monitoring business development transactions and competitive activity across the industry
Assisting in the execution of relevant corporate transactions by providing supporting information (e.g., valuation estimates, due diligence materials, ad-hoc deal analytics)
EDUCATION & EXPERIENCE:
Bachelor's degree in finance, business, engineering, or a related field; MBA preferred
At least 5 years total working experience across biotech, pharmaceuticals, strategy consulting, management consulting, or data analytics related roles; public company exposure preferred
Previous roles in IR, commercial analytics, or the finance function are advantageous, but not required; strong aptitude for learning and growth potential prioritized
Exceptional oral and written communication skills, including the ability to simplify and explain complex topics to various audiences (e.g., financials, modeling/analytics, scientific data)
Ability to craft clear, concise, and visually appealing messages through presentation building; proficiency in Microsoft PowerPoint required
Familiarity with financial concepts and model building (e.g., accounting, DCF valuation, forecasting); proficiency in Microsoft Excel required
Excellent organizational skills with an ability to effectively coordinate multiple projects, prioritize based on criticality, and deliver quickly
Capacity to digest data sets, organize information, draw conclusions, and predict implications